Drawing upon over 20 years of experience in strategic planning and marketing for health care delivery, financing and biotechnology organizations, Chris Causey provides leadership, vision and objective counsel to a broad range of clients within the health care industry. His work is characterized by its strategic focus, entrepreneurial energy, contagious enthusiasm, humor and creativity. He has launched numerous innovative programs which have earned national and international recognition.
Chris's management experience includes:
In addition to his consulting practice, Chris serves on the Board of Directors of two biotechnology companies. Since 2003, he has been a director at United Therapeutics Corporation (NASDAQ: UTHR), a rapidly growing mid-cap company engaged in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases. Since his election to the board, Chris has served as Chair of the Compensation Committee. His other committee assignments include the Scientific Committee, six years on the Audit Committee and as of 2011 the Nominating/Governance Committee.
Since 2008, Chris has also been a member of the Board of Directors of Data Sciences International, Inc., a privately-held company and market leader that develops wireless physiological monitoring solutions for pre-clinical pharmaceutical and biotechnology research.
To learn more, visit www.linkedin.com/pub/christopher-causey/48/862/793
Content and Design © Copyright, Causey Consortium, 2012. All Rights Reserved.